FDAHealthMay 28, 2026
Ajanta Pharma USA Inc — Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120
⚠️ CGMP Deviations
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- May 28, 2026
U.S. Nationwide
What's affected?
- Product
- Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.
- Brand
- FENOFIBRATE
- UPC
- 0327241119040
- Lot code
- PA02216
Additional details
Lot # PA02216; Exp. 12/2029
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 3648 bottles.
Get Health recall alerts
Delivered to your inbox. Free. No account required.